Evaluation of cardiotoxicity and other adverse effects associated with concomitant administration of artemether/lumefantrine and atazanavir/ritonavir-based antiretroviral regimen in patients living with HIV
The interplay of artemether-lumefantrine (AL) and atazanavir-ritonavir (ATVr) with Cytochrome P (CYP) 3A4 isoenzyme and QTc-interval may spawn clinically significant drug interactions when administered concomitantly. Cardiotoxicity and other adverse effects associated with interaction between AL and...
保存先:
| 主要な著者: | , , , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer
2022-05-01
|
| シリーズ: | Saudi Pharmaceutical Journal |
| 主題: | |
| オンライン･アクセス: | http://www.sciencedirect.com/science/article/pii/S1319016422000512 |
| タグ: |
タグなし, このレコードへの初めてのタグを付けませんか!
|